Go Pro

CRH (CRH) Financials

CRH logo
$97.54 +2.53 (+2.67%)
As of 02:19 PM Eastern
This is a fair market value price provided by Massive. Learn more.
Annual Income Statements for CRH

Annual Income Statements for CRH

This table shows CRH's income and expenses over time, based on annual financial data. All values are USD millions unless otherwise specified.

Metric 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
Period end date 12/31/2015 12/31/2016 12/31/2017 12/31/2018 12/31/2019 12/31/2020 12/31/2021 12/31/2022 12/31/2023 12/31/2024 12/31/2025
Net Income / (Loss) Attributable to Common Shareholders
685 1,280 2,240 2,889 - 1,304 2,630 3,862 3,178 3,492 3,753
Consolidated Net Income / (Loss)
792 1,336 2,305 2,889 1,738 1,165 2,686 3,889 3,072 3,521 3,790
Net Income / (Loss) Continuing Operations
700 1,251 2,010 1,526 - 1,009 2,507 2,699 3,072 3,521 3,790
Total Pre-Tax Income
1,000 1,704 2,024 1,993 - 1,454 3,102 3,461 4,014 4,714 4,805
Total Operating Income
1,267 2,007 2,315 2,446 - 2,026 3,327 3,809 4,186 4,925 5,440
Total Gross Profit
7,240 8,651 8,863 9,058 9,273 8,565 9,827 10,815 11,963 12,701 13,528
Total Revenue
23,259 26,078 26,011 27,424 - 25,888 29,206 32,723 34,949 35,572 37,447
Operating Revenue
23,259 26,078 26,011 27,424 - 25,888 29,206 32,723 34,949 35,572 37,447
Total Cost of Revenue
16,019 17,427 17,148 18,391 - 17,323 19,379 21,908 22,986 22,871 23,919
Operating Cost of Revenue
16,019 17,427 17,148 18,391 - 17,323 19,379 21,908 22,986 22,871 23,919
Total Operating Expenses
5,973 6,643 6,548 6,612 - 6,539 6,500 7,006 7,777 7,776 8,088
Selling, General & Admin Expense
- - - - - - 6,538 7,056 7,486 7,852 8,283
Impairment Charge
- - - - - - 0.00 0.00 357 161 40
Other Special Charges / (Income)
- - - - - - -38 -50 -66 -237 -235
Total Other Income / (Expense), net
-375 -359 -356 -453 - -589 -225 -348 -172 -211 -635
Interest Expense
431 411 362 - - 438 315 344 376 612 810
Interest & Investment Income
8.69 8.42 14 - - 0.00 0.00 65 206 143 146
Other Income / (Expense), net
48 44 -8.41 -453 - -151 90 -69 -2.00 258 29
Income Tax Expense
300 453 14 467 - 445 650 762 925 1,085 1,041
Other Gains / (Losses), net
- - - - - - 55 0.00 -17 -108 26
Net Income / (Loss) Attributable to Noncontrolling Interest
- - - - - - 56 27 -106 29 37
Basic Earnings per Share
$0.89 $1.50 $2.72 - - $1.43 $3.35 $5.15 $4.36 $5.06 $5.54
Weighted Average Basic Shares Outstanding
- - 838.96M 843.39M 799.64M 795.14M 780.20M 758.30M 723.90M 683.30M 673.20M
Diluted Earnings per Share
$0.89 $1.49 $2.71 - - $1.42 $3.32 $5.11 $4.33 $5.02 $5.51
Weighted Average Diluted Shares Outstanding
- - 838.96M 843.39M 799.64M 795.14M 786.80M 764.10M 729.20M 689.50M 677M
Weighted Average Basic & Diluted Shares Outstanding
- - 838.96M 843.39M 799.64M 795.14M 774.14M 752.14M 690.36M 676.48M 668.25M
Cash Dividends to Common per Share
- - - - - - $1.21 $1.27 $1.33 $1.40 $1.48

Quarterly Income Statements for CRH

This table shows CRH's income and expenses over time, based on quarterly financial data. All values are USD millions unless otherwise specified.

Metric Q4 2023 Q1 2024 Q2 2024 Q3 2024 Q4 2024 Q1 2025 Q2 2025 Q3 2025 Q4 2025 Q1 2026 Q2 2026
Period end date 12/31/2023 3/31/2024 6/30/2024 9/30/2024 12/31/2024 3/31/2025 6/30/2025 9/30/2025 12/31/2025 3/31/2026 6/30/2026
Net Income / (Loss) Attributable to Common Shareholders
701 116 1,297 1,376 703 -94 1,319 1,503 1,025 -176 1,486
Consolidated Net Income / (Loss)
573 114 1,309 1,389 709 -98 1,332 1,519 1,037 -180 1,511
Net Income / (Loss) Continuing Operations
573 114 1,309 1,389 709 -98 1,332 1,519 1,037 -180 1,511
Total Pre-Tax Income
755 99 1,733 1,895 987 -146 1,756 1,921 1,274 -224 2,163
Total Operating Income
783 28 1,829 1,964 1,104 18 1,935 2,081 1,406 -38 2,079
Total Gross Profit
2,951 1,807 3,675 4,059 3,160 1,837 4,026 4,309 3,356 2,045 4,294
Total Revenue
8,685 6,533 9,654 10,515 8,870 6,756 10,206 11,069 9,416 7,370 10,777
Operating Revenue
8,685 6,533 9,654 10,515 8,870 6,756 10,206 11,069 9,416 7,370 10,777
Total Cost of Revenue
5,734 4,726 5,979 6,456 5,710 4,919 6,180 6,760 6,060 5,325 6,483
Operating Cost of Revenue
5,734 4,726 5,979 6,456 5,710 4,919 6,180 6,760 6,060 5,325 6,483
Total Operating Expenses
2,168 1,779 1,846 2,095 2,056 1,819 2,091 2,228 1,950 2,083 2,215
Selling, General & Admin Expense
1,839 1,787 1,948 2,184 1,933 1,833 2,120 2,338 1,992 2,057 2,267
Impairment Charge
- - - - - 0.00 0.00 - - 48 0.00
Other Special Charges / (Income)
-28 -8.00 -102 -89 -38 -14 -29 -110 -82 -22 -52
Total Other Income / (Expense), net
-28 71 -96 -69 -117 -164 -179 -160 -132 -186 84
Interest Expense
91 133 155 164 160 181 200 209 220 203 220
Interest & Investment Income
68 43 36 33 31 37 30 37 42 21 22
Other Income / (Expense), net
-5.00 161 23 62 12 -20 -9.00 12 46 -4.00 282
Income Tax Expense
144 -19 430 531 143 -58 425 428 246 -55 661
Other Gains / (Losses), net
-38 -4.00 6.00 25 -135 -10 1.00 26 9.00 -11 9.00
Net Income / (Loss) Attributable to Noncontrolling Interest
-128 -2.00 12 13 6.00 -4.00 13 16 12 -4.00 25
Basic Earnings per Share
$0.97 $0.16 $1.89 $1.99 $1.02 ($0.15) $1.95 $2.23 $1.51 ($0.27) $2.22
Weighted Average Basic Shares Outstanding
723.90M 687.80M 685.50M 681.60M 683.30M 676.70M 674.80M 672.30M 673.20M 668.50M 667.20M
Diluted Earnings per Share
$0.96 $0.16 $1.88 $1.97 $1.01 ($0.15) $1.94 $2.21 $1.51 ($0.27) $2.21
Weighted Average Diluted Shares Outstanding
729.20M 693.40M 688.80M 685.50M 689.50M 676.70M 677.70M 675.50M 677M 668.50M 668.80M
Weighted Average Basic & Diluted Shares Outstanding
690.36M 686.68M 682.78M 679.34M 676.48M 676.00M 672.66M 670.27M 668.25M 668.20M 665.28M

Annual Cash Flow Statements for CRH

This table details how cash moves in and out of CRH's business through operations, investing, and financing, using annual figures. All values are USD millions unless otherwise specified.

Metric 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
Period end date 12/31/2015 12/31/2016 12/31/2017 12/31/2018 12/31/2019 12/31/2020 12/31/2021 12/31/2022 12/31/2023 12/31/2024 12/31/2025
Net Change in Cash & Equivalents
-4,181 -4,133 -5,388 -5,946 1,552 3,466 -1,938 153 454 -2,631 388
Net Cash From Operating Activities
1,057 -1,510 -2,392 -3,885 3,881 4,116 3,979 3,800 5,017 4,989 5,625
Net Cash From Continuing Operating Activities
1,057 -1,510 -2,392 -3,885 2,580 4,116 3,979 3,800 5,017 4,989 5,625
Net Income / (Loss) Continuing Operations
0.00 0.00 0.00 0.00 2,181 1,165 2,686 3,889 3,072 3,521 3,790
Consolidated Net Income / (Loss)
- - - - 2,181 1,165 2,686 3,889 3,072 3,521 3,790
Depreciation Expense
916 1,061 1,208 1,265 1,721 1,624 1,551 1,577 1,633 1,798 2,156
Non-Cash Adjustments To Reconcile Net Income
205 -2,511 -3,285 -4,539 -1,024 1,185 27 -1,242 547 -14 -84
Changes in Operating Assets and Liabilities, net
-64 -60 -315 -611 -364 142 -285 -424 -235 -316 -237
Net Cash From Investing Activities
-8,886 -1,054 -3,466 -5,400 217 -1,347 -2,513 -917 -2,391 -6,291 -6,045
Net Cash From Continuing Investing Activities
-8,886 -1,054 -3,466 -5,400 -2,040 -1,347 -2,513 -917 -2,391 -6,291 -6,045
Purchase of Property, Plant & Equipment
- - -1,254 -1,324 -1,374 -996 -1,554 -1,523 -1,817 -2,578 -2,713
Acquisitions
- - -2,211 -4,076 -727 -351 -1,494 -3,253 -640 -4,900 -3,856
Purchase of Investments
- - - - - - 0.00 -11 -1.00 -9.00 -81
Sale of Property, Plant & Equipment
-958 -897 - - - - 387 115 104 272 315
Divestitures
-7,927 -157 - - - - 120 3,712 0.00 1,001 139
Sale and/or Maturity of Investments
- - - - 39 - 32 36 44 44 50
Other Investing Activities, net
- - - - 22 - -4.00 7.00 -81 -121 101
Net Cash From Financing Activities
3,648 -1,570 470 3,339 2,546 697 -3,107 -2,499 -2,380 -1,186 596
Net Cash From Continuing Financing Activities
3,648 -1,570 470 3,339 -2,485 697 -3,107 -2,499 -2,380 -1,186 596
Repayment of Debt
-41 0.00 -434 -291 -996 -4,943 -1,183 -364 -1,462 -1,859 -7,612
Repurchase of Common Equity
- - -3.60 -921 -954 -249 -896 -1,178 -3,067 -1,482 -1,181
Payment of Dividends
-416 -379 -573 -633 -663 -722 -946 -943 -977 -1,740 -1,002
Issuance of Debt
4,105 -1,191 1,480 5,184 106 6,611 0.00 38 3,163 4,001 10,479
Other Financing Activities, net
- - - - 22 - -82 -52 -37 -106 -88
Effect of Exchange Rate Changes
- - - - - - -297 -231 208 -143 212
Cash Interest Paid
328 364 381 394 - 432 340 329 418 599 724
Cash Income Taxes Paid
- - - - - - 642 1,043 959 960 831

Quarterly Cash Flow Statements for CRH

This table details how cash moves in and out of CRH's business through operations, investing, and financing, using quarterly figures. All values are USD millions unless otherwise specified.

Metric Q4 2023 Q1 2024 Q2 2024 Q3 2024 Q4 2024 Q1 2025 Q2 2025 Q3 2025 Q4 2025 Q1 2026 Q2 2026
Period end date 12/31/2023 3/31/2024 6/30/2024 9/30/2024 12/31/2024 3/31/2025 6/30/2025 9/30/2025 12/31/2025 3/31/2026 6/30/2026
Net Change in Cash & Equivalents
668 -3,081 637 -866 679 -407 -476 1,412 -141 -814 -250
Net Cash From Operating Activities
2,423 -712 1,485 1,486 2,730 -659 1,378 1,991 2,915 -616 1,129
Net Cash From Continuing Operating Activities
2,423 -712 1,485 1,486 2,730 -659 1,378 1,991 2,915 -616 1,129
Net Income / (Loss) Continuing Operations
573 114 1,309 1,389 709 -98 1,332 1,519 1,037 -180 1,511
Consolidated Net Income / (Loss)
573 114 1,309 1,389 709 -98 1,332 1,519 1,037 -180 1,511
Depreciation Expense
446 397 424 467 510 477 528 601 550 576 548
Non-Cash Adjustments To Reconcile Net Income
451 -105 -80 -155 326 16 42 -93 -49 -85 -119
Changes in Operating Assets and Liabilities, net
953 -1,118 -168 -215 1,185 -1,054 -524 -36 1,377 -1,010 -728
Net Cash From Investing Activities
-662 -2,096 -521 -1,788 -1,886 -964 -831 -2,910 -1,340 -722 134
Net Cash From Continuing Investing Activities
-668 -2,096 -521 -1,788 -1,886 -964 -831 -2,910 -1,340 -722 134
Purchase of Property, Plant & Equipment
-642 -506 -624 -505 -943 -645 -655 -592 -821 -601 -639
Acquisitions
-79 -2,206 -316 -1,331 -1,047 -585 -63 -2,473 -735 -126 -984
Purchase of Investments
-4.00 -13 10 -18 12 20 -53 -39 -9.00 -24 -9.00
Sale of Property, Plant & Equipment
40 10 357 84 -908 35 30 118 132 28 68
Divestitures
-5.00 729 - 27 919 36 1.00 15 87 6.00 1,670
Other Investing Activities, net
1.00 -116 -12 -52 59 166 -95 51 -21 -5.00 28
Net Cash From Financing Activities
-1,283 -176 -339 -629 -42 1,141 -1,153 2,331 -1,723 572 -1,521
Net Cash From Continuing Financing Activities
-1,281 -176 -339 -629 -42 1,141 -1,153 2,331 -1,723 570 -1,519
Repayment of Debt
-522 -651 -1,040 -163 -5.00 -1,533 -1,819 -345 -3,915 -207 -922
Repurchase of Common Equity
-1,036 -559 -348 -317 -258 -310 -334 -286 -251 -332 -275
Payment of Dividends
-179 -767 -486 -249 -238 -17 -503 -258 -224 -39 -529
Issuance of Debt
476 1,818 1,552 82 549 3,017 1,525 3,218 2,719 1,212 340
Other Financing Activities, net
-20 -17 -17 18 -90 -16 -22 2.00 -52 -64 -133
Effect of Exchange Rate Changes
190 -97 12 65 -123 75 130 - 7.00 -48 8.00
Cash Interest Paid
174 45 171 156 227 63 188 243 230 160 175
Cash Income Taxes Paid
339 159 145 350 306 134 170 76 451 39 365

Annual Balance Sheets for CRH

This table presents CRH's assets and liabilities at the end of each period, using annual balance sheet data. All values are USD millions unless otherwise specified.

Metric 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
Period end date 12/31/2016 12/31/2017 12/31/2018 12/31/2019 12/31/2020 12/31/2021 12/31/2022 12/31/2023 12/31/2024 12/31/2025
Total Assets
33,237 37,999 46,777 47,612 44,944 44,670 45,319 47,469 50,613 58,329
Total Current Assets
9,882 11,737 17,395 17,258 14,977 14,044 14,833 16,885 14,083 15,254
Cash & Equivalents
2,576 2,541 9,191 9,918 7,721 5,783 5,936 6,341 3,720 4,096
Restricted Cash
- - - - - - - 0.00 39 51
Accounts Receivable
4,186 4,361 4,665 4,231 4,086 4,569 4,300 4,507 4,820 5,178
Inventories, net
3,092 3,261 3,505 3,080 3,117 3,611 4,194 4,291 4,755 5,251
Other Current Assets
- - - - - - 403 478 749 678
Plant, Property, & Equipment, net
13,350 15,729 18,046 19,574 19,317 19,502 17,768 17,841 21,452 24,937
Total Noncurrent Assets
10,005 10,533 11,336 10,780 10,650 11,124 12,718 12,743 15,078 18,138
Long-Term Investments
1,367 1,499 1,332 775 626 653 649 620 737 502
Goodwill
- - - - - - 9,199 9,158 11,061 13,099
Intangible Assets
8,165 8,666 9,656 9,475 9,373 9,848 1,088 1,041 1,211 2,048
Other Noncurrent Operating Assets
83 66 60 98 197 275 1,782 1,924 2,069 2,489
Total Liabilities & Shareholders' Equity
33,237 37,999 46,777 47,612 44,944 44,670 45,319 47,469 50,613 58,329
Total Liabilities
18,043 20,008 27,825 27,977 24,596 23,756 22,279 25,848 27,763 32,851
Total Current Liabilities
6,690 7,516 14,006 13,411 7,465 7,581 8,041 10,013 10,296 8,754
Short-Term Debt
289 380 7,213 6,616 1,257 549 1,491 1,866 2,999 1,175
Accounts Payable
5,550 5,718 5,817 5,461 5,503 6,409 2,930 3,149 3,207 3,263
Accrued Expenses
- - - - - - 2,132 2,296 2,248 2,196
Other Current Liabilities
436 869 468 769 797 790 1,488 2,327 1,842 2,120
Total Noncurrent Liabilities
11,353 12,492 13,819 14,566 17,131 16,175 14,238 15,835 17,467 24,097
Long-Term Debt
7,906 9,202 9,959 9,211 10,958 9,938 8,145 9,776 10,969 16,478
Noncurrent Deferred & Payable Income Tax Liabilities
2,112 2,001 2,530 2,627 2,613 2,734 2,885 2,738 3,105 3,511
Other Noncurrent Operating Liabilities
713 836 844 855 954 937 3,208 3,321 3,393 4,108
Commitments & Contingencies
- - - - - - 0.00 0.00 0.00 0.00
Redeemable Noncontrolling Interest
- - - - - - 308 333 384 430
Total Equity & Noncontrolling Interests
15,193 17,990 18,951 19,634 20,347 20,914 22,732 21,288 22,466 25,048
Total Preferred & Common Equity
14,616 17,406 18,349 19,027 40,004 20,233 22,157 20,854 21,607 24,004
Preferred Stock
- - - - 7,493 - 1.00 1.00 1.00 1.00
Total Common Equity
14,616 17,406 18,349 19,027 12,162 20,232 22,156 20,853 21,606 24,003
Common Stock
299 344 352 335 333 309 745 750 712 683
Retained Earnings
6,809 9,493 11,705 11,350 11,565 19,770 22,495 22,918 24,036 25,593
Treasury Stock
-15 -18 -920 -360 -386 -195 -297 -2,199 -2,137 -2,016
Accumulated Other Comprehensive Income / (Loss)
- - - - - - -787 -616 -1,005 -257
Noncontrolling Interest
576 584 602 607 692 681 575 434 859 1,044

Quarterly Balance Sheets for CRH

This table presents CRH's assets and liabilities at the end of each period, using quarterly balance sheet data. All values are USD millions unless otherwise specified.

Metric Q1 2023 Q2 2023 Q3 2023 Q1 2024 Q2 2024 Q3 2024 Q1 2025 Q2 2025 Q3 2025 Q1 2026 Q2 2026
Period end date 3/31/2023 6/30/2023 9/30/2023 3/31/2024 6/30/2024 9/30/2024 3/31/2025 6/30/2025 9/30/2025 3/31/2026 6/30/2026
Total Assets
45,107 46,142 47,631 46,333 48,105 51,221 51,921 53,984 58,527 58,167 58,552
Total Current Assets
14,230 15,074 16,315 13,709 15,113 14,840 14,242 15,151 16,852 16,239 15,752
Cash & Equivalents
4,650 4,275 5,722 3,308 3,066 2,978 3,352 2,876 4,198 3,240 3,025
Restricted Cash
- 0.00 0.00 0.00 869 102 0.00 0.00 90 40 58
Accounts Receivable
4,706 6,119 5,972 4,798 5,893 6,422 5,141 6,490 6,961 5,213 6,777
Inventories, net
4,458 4,276 4,191 4,619 4,514 4,644 4,960 5,051 5,019 5,058 5,103
Other Current Assets
416 404 430 748 704 694 789 734 584 877 789
Plant, Property, & Equipment, net
17,997 18,155 18,103 18,878 19,235 21,289 22,179 23,017 23,783 24,657 24,885
Total Noncurrent Assets
12,880 12,913 13,213 13,746 13,757 15,092 15,500 15,816 17,892 17,271 17,915
Long-Term Investments
655 672 665 609 484 929 732 712 743 487 464
Goodwill
9,308 9,338 9,545 10,125 10,251 10,906 11,475 11,673 12,676 12,592 13,150
Intangible Assets
1,094 1,061 1,074 1,093 1,086 1,105 1,208 1,239 2,146 1,956 2,037
Other Noncurrent Operating Assets
1,823 1,842 1,929 1,919 1,936 2,152 2,085 2,192 2,327 2,236 2,264
Total Liabilities & Shareholders' Equity
45,107 46,142 47,631 46,333 48,105 51,221 51,921 53,984 58,527 58,167 58,552
Total Liabilities
22,963 23,433 24,983 25,591 26,654 28,055 29,564 30,354 33,898 33,622 33,017
Total Current Liabilities
9,255 9,671 9,191 9,997 10,548 10,668 8,712 8,684 11,596 10,211 9,977
Short-Term Debt
2,251 2,185 1,860 2,992 3,218 3,218 1,458 1,171 3,968 2,478 2,516
Accounts Payable
2,627 3,553 2,954 2,730 3,363 2,963 2,777 3,303 3,156 2,947 3,535
Accrued Expenses
2,079 2,335 2,457 2,241 2,272 2,513 2,270 2,266 2,393 2,143 2,046
Other Current Liabilities
2,298 1,598 1,920 1,990 1,681 1,974 2,207 1,944 2,079 2,215 1,880
Total Noncurrent Liabilities
13,708 13,762 15,792 15,594 16,106 17,387 20,852 21,670 22,302 23,411 23,040
Long-Term Debt
7,583 7,563 9,535 9,680 9,900 10,672 14,213 14,642 14,734 16,071 15,410
Noncurrent Deferred & Payable Income Tax Liabilities
2,972 3,010 3,050 2,684 2,914 3,168 3,141 3,202 3,595 3,301 3,509
Other Noncurrent Operating Liabilities
3,153 3,189 3,207 3,230 3,292 3,547 3,498 3,826 3,973 4,039 4,121
Commitments & Contingencies
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Redeemable Noncontrolling Interest
307 313 320 326 335 361 379 389 419 422 435
Total Equity & Noncontrolling Interests
21,837 22,396 22,328 20,416 21,116 22,805 21,978 23,241 24,210 24,123 25,100
Total Preferred & Common Equity
21,255 21,821 21,767 20,015 20,726 21,875 21,119 22,345 23,309 23,071 24,035
Preferred Stock
1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 0.00
Total Common Equity
21,254 21,820 21,766 20,014 20,725 21,874 21,118 22,344 23,308 23,070 24,035
Common Stock
722 693 725 631 651 683 587 611 648 535 569
Retained Earnings
21,692 22,892 23,936 22,346 23,030 23,831 23,375 24,106 25,068 24,793 25,738
Treasury Stock
-487 -1,140 -2,132 -2,166 -2,143 -2,141 -2,038 -2,028 -2,027 -1,905 -1,896
Accumulated Other Comprehensive Income / (Loss)
-673 -625 -763 -797 -813 -499 -806 -345 -381 -353 -376
Noncontrolling Interest
582 575 561 401 390 930 859 896 901 1,052 1,065

Annual Metrics And Ratios for CRH

This table displays calculated financial ratios and metrics derived from CRH's official financial filings.

Metric 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
Period end date 12/31/2015 12/31/2016 12/31/2017 12/31/2018 12/31/2019 12/31/2020 12/31/2021 12/31/2022 12/31/2023 12/31/2024 12/31/2025
Growth Metrics
- - - - - - - - - - -
Revenue Growth
0.00% 12.12% -0.26% 5.43% 0.00% 0.00% 12.82% 12.04% 6.80% 1.78% 5.27%
EBITDA Growth
0.00% 39.55% 12.91% -9.14% -45.15% 95.80% 41.98% 7.03% 9.40% 20.01% 9.23%
EBIT Growth
0.00% 56.03% 12.43% -16.16% -100.00% 0.00% 82.24% 9.45% 11.87% 23.88% 5.52%
NOPAT Growth
0.00% 66.12% 56.01% -18.51% -100.00% 0.00% 87.05% 12.95% 8.45% 17.70% 12.40%
Net Income Growth
0.00% 68.67% 72.54% 25.33% -39.84% -32.97% 130.56% 44.79% -21.01% 14.62% 7.64%
EPS Growth
0.00% 68.09% 81.60% 0.00% 0.00% 0.00% 133.80% 53.92% -15.26% 15.94% 9.76%
Operating Cash Flow Growth
0.00% -242.79% -58.43% -62.44% 199.90% 6.06% -3.33% -4.50% 32.03% -0.56% 12.75%
Free Cash Flow Firm Growth
0.00% 0.00% 97.57% -257.21% 63.29% 454.28% -7.67% 70.22% 22.77% -179.97% 39.18%
Invested Capital Growth
0.00% 0.00% 14.08% 15.47% 2.23% -2.36% 2.98% -0.79% -2.61% 27.21% 19.06%
Revenue Q/Q Growth
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.52% 1.48%
EBITDA Q/Q Growth
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 6.11% 5.19%
EBIT Q/Q Growth
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 6.98% 6.55%
NOPAT Q/Q Growth
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 8.69% 4.67%
Net Income Q/Q Growth
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 4.02% 9.47%
EPS Q/Q Growth
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 1.01% 9.98%
Operating Cash Flow Q/Q Growth
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 6.56% 3.40%
Free Cash Flow Firm Q/Q Growth
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% -60.66%
Invested Capital Q/Q Growth
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% -2.19% 0.48%
Profitability Metrics
- - - - - - - - - - -
Gross Margin
31.13% 33.17% 34.07% 33.03% 0.00% 33.08% 33.65% 33.05% 34.23% 35.71% 36.13%
EBITDA Margin
9.59% 11.94% 13.51% 11.88% 0.00% 13.52% 17.01% 16.25% 16.64% 19.63% 20.36%
Operating Margin
5.45% 7.70% 8.90% 8.92% 0.00% 7.83% 11.39% 11.64% 11.98% 13.85% 14.53%
EBIT Margin
5.65% 7.87% 8.87% 7.27% 0.00% 7.24% 11.70% 11.43% 11.97% 14.57% 14.60%
Profit (Net Income) Margin
3.41% 5.12% 8.86% 10.53% 0.00% 4.50% 9.20% 11.88% 8.79% 9.90% 10.12%
Tax Burden Percent
79.24% 78.40% 113.89% 144.96% 0.00% 80.12% 86.59% 112.37% 76.53% 74.69% 78.88%
Interest Burden Percent
76.03% 83.08% 87.76% 100.00% 0.00% 77.55% 90.78% 92.54% 95.94% 90.95% 87.86%
Effective Tax Rate
30.00% 26.60% 0.71% 23.43% 0.00% 30.61% 20.95% 22.02% 23.04% 23.02% 21.66%
Return on Invested Capital (ROIC)
0.00% 15.17% 11.06% 7.85% 0.00% 5.44% 10.15% 11.34% 12.51% 13.13% 12.04%
ROIC Less NNEP Spread (ROIC-NNEP)
0.00% 8.68% 11.22% 26.67% 0.00% 1.33% 11.21% 33.12% 8.14% 9.06% 7.84%
Return on Net Nonoperating Assets (RNNOA)
0.00% 2.42% 2.84% 7.80% 0.00% 0.39% 2.87% 6.36% 1.25% 2.70% 3.65%
Return on Equity (ROE)
0.00% 17.59% 13.89% 15.64% 9.01% 5.83% 13.02% 17.70% 13.76% 15.84% 15.68%
Cash Return on Invested Capital (CROIC)
0.00% -184.83% -2.09% -6.52% -2.21% 7.83% 7.21% 12.14% 15.16% -10.81% -5.36%
Operating Return on Assets (OROA)
0.00% 6.17% 6.48% 4.70% 0.00% 4.05% 7.63% 8.31% 9.02% 10.57% 10.04%
Return on Assets (ROA)
0.00% 4.02% 6.47% 6.82% 0.00% 2.52% 5.99% 8.64% 6.62% 7.18% 6.96%
Return on Common Equity (ROCE)
0.00% 16.92% 13.41% 15.14% 8.73% 4.55% 10.22% 17.07% 13.25% 15.12% 14.80%
Return on Equity Simple (ROE_SIMPLE)
0.00% 9.14% 13.24% 15.74% 9.13% 2.91% 13.28% 17.55% 14.73% 16.30% 0.00%
Net Operating Profit after Tax (NOPAT)
887 1,473 2,298 1,873 0.00 1,406 2,630 2,970 3,221 3,791 4,261
NOPAT Margin
3.81% 5.65% 8.84% 6.83% 0.00% 5.43% 9.00% 9.08% 9.22% 10.66% 11.38%
Net Nonoperating Expense Percent (NNEP)
0.00% 6.49% -0.16% -18.82% -26.43% 4.11% -1.06% -21.78% 4.37% 4.08% 4.19%
Return On Investment Capital (ROIC_SIMPLE)
- - - - - - - 9.18% 9.78% 10.41% 9.98%
Cost of Revenue to Revenue
68.87% 66.83% 65.93% 67.06% 0.00% 66.92% 66.35% 66.95% 65.77% 64.30% 63.87%
SG&A Expenses to Revenue
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 22.39% 21.56% 21.42% 22.07% 22.12%
R&D to Revenue
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Operating Expenses to Revenue
25.68% 25.48% 25.17% 24.11% 0.00% 25.26% 22.26% 21.41% 22.25% 21.86% 21.60%
Earnings before Interest and Taxes (EBIT)
1,315 2,051 2,306 1,993 0.00 1,875 3,417 3,740 4,184 5,183 5,469
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)
2,231 3,113 3,515 3,258 1,787 3,499 4,968 5,317 5,817 6,981 7,625
Valuation Ratios
- - - - - - - - - - -
Price to Book Value (P/BV)
0.00 0.00 0.00 1.09 1.65 2.68 2.03 1.30 2.46 2.91 3.49
Price to Tangible Book Value (P/TBV)
0.00 0.00 0.00 2.29 3.29 11.67 3.96 2.43 4.81 6.73 9.45
Price to Revenue (P/Rev)
0.00 0.00 0.00 0.73 0.00 1.26 1.41 0.88 1.46 1.77 2.23
Price to Earnings (P/E)
0.00 0.00 0.00 6.90 0.00 24.95 15.65 7.46 16.11 18.00 22.29
Dividend Yield
2.84% 2.38% 2.27% 3.41% 2.15% 2.23% 2.26% 0.00% 1.95% 0.00% 0.00%
Earnings Yield
0.00% 0.00% 0.00% 14.48% 0.00% 4.01% 6.39% 13.41% 6.21% 5.56% 4.49%
Enterprise Value to Invested Capital (EV/IC)
0.00 0.00 0.00 1.06 1.48 1.80 1.80 1.25 2.23 2.28 2.55
Enterprise Value to Revenue (EV/Rev)
0.00 0.00 0.00 0.99 0.00 1.77 1.62 1.00 1.62 2.07 2.62
Enterprise Value to EBITDA (EV/EBITDA)
0.00 0.00 0.00 8.34 21.60 13.12 9.51 6.16 9.74 10.54 12.87
Enterprise Value to EBIT (EV/EBIT)
0.00 0.00 0.00 13.64 0.00 24.49 13.82 8.75 13.54 14.19 17.94
Enterprise Value to NOPAT (EV/NOPAT)
0.00 0.00 0.00 14.51 0.00 32.65 17.96 11.02 17.58 19.40 23.03
Enterprise Value to Operating Cash Flow (EV/OCF)
0.00 0.00 0.00 0.00 9.95 11.15 11.87 8.62 11.29 14.75 17.45
Enterprise Value to Free Cash Flow (EV/FCFF)
0.00 0.00 0.00 0.00 0.00 22.69 25.28 10.30 14.51 0.00 0.00
Leverage & Solvency
- - - - - - - - - - -
Debt to Equity
0.00 0.54 0.53 0.91 0.88 0.67 0.57 0.42 0.54 0.61 0.69
Long-Term Debt to Equity
0.00 0.52 0.51 0.53 0.54 0.60 0.54 0.35 0.45 0.48 0.65
Financial Leverage
0.00 0.28 0.25 0.29 0.34 0.29 0.26 0.19 0.15 0.30 0.47
Leverage Ratio
0.00 2.19 2.15 2.29 2.45 2.32 2.17 2.05 2.08 2.21 2.25
Compound Leverage Factor
0.00 1.82 1.88 2.29 0.00 1.80 1.97 1.89 1.99 2.01 1.98
Debt to Total Capital
0.00% 35.04% 34.75% 47.54% 46.72% 39.98% 36.19% 29.49% 35.00% 37.94% 40.93%
Short-Term Debt to Total Capital
0.00% 1.24% 1.38% 19.97% 17.95% 3.71% 1.68% 4.56% 5.61% 8.15% 2.72%
Long-Term Debt to Total Capital
0.00% 33.80% 33.37% 27.57% 28.77% 36.27% 34.51% 24.93% 29.39% 29.79% 38.20%
Preferred Equity to Total Capital
0.00% 0.00% 0.00% 0.00% 0.00% 22.10% 0.00% 0.00% 0.00% 0.00% 0.00%
Noncontrolling Interests to Total Capital
0.00% 2.46% 2.12% 1.67% 1.65% 2.04% 2.08% 2.70% 2.31% 3.38% 3.42%
Common Equity to Total Capital
0.00% 62.50% 63.13% 50.80% 51.63% 35.88% 61.73% 67.81% 62.69% 58.68% 55.65%
Debt to EBITDA
0.00 2.63 2.73 5.27 9.64 3.87 2.39 1.81 2.00 2.00 2.32
Net Debt to EBITDA
0.00 1.36 1.56 2.04 3.65 1.48 1.08 0.57 0.80 1.36 1.71
Long-Term Debt to EBITDA
0.00 2.54 2.62 3.06 5.93 3.51 2.28 1.53 1.68 1.57 2.16
Debt to NOPAT
0.00 5.56 4.17 9.17 0.00 9.64 4.51 3.24 3.61 3.68 4.14
Net Debt to NOPAT
0.00 2.87 2.39 3.54 0.00 3.69 2.05 1.03 1.45 2.50 3.05
Long-Term Debt to NOPAT
0.00 5.37 4.00 5.32 0.00 8.75 4.30 2.74 3.03 2.89 3.87
Altman Z-Score
0.00 0.00 0.00 1.59 1.11 2.07 2.74 2.64 3.07 3.15 3.23
Noncontrolling Interest Sharing Ratio
0.00% 3.79% 3.50% 3.21% 3.13% 21.99% 21.49% 3.56% 3.70% 4.52% 5.63%
Liquidity Ratios
- - - - - - - - - - -
Current Ratio
0.00 1.48 1.56 1.24 1.29 2.01 1.85 1.84 1.69 1.37 1.74
Quick Ratio
0.00 1.01 0.92 0.99 1.06 1.58 1.37 1.27 1.08 0.83 1.06
Cash Flow Metrics
- - - - - - - - - - -
Free Cash Flow to Firm (FCFF)
0.00 -17,949 -435 -1,555 -571 2,023 1,868 3,179 3,903 -3,122 -1,899
Operating Cash Flow to CapEx
110.32% -168.23% -190.71% -293.43% 282.46% 413.25% 340.96% 269.89% 292.88% 216.35% 234.57%
Free Cash Flow to Firm to Interest Expense
0.00 -43.64 -1.20 0.00 0.00 4.62 5.93 9.24 10.38 -5.10 -2.34
Operating Cash Flow to Interest Expense
2.45 -3.67 -6.61 0.00 0.00 9.40 12.63 11.05 13.34 8.15 6.94
Operating Cash Flow Less CapEx to Interest Expense
0.23 -5.85 -10.08 0.00 0.00 7.12 8.93 6.95 8.79 4.38 3.98
Efficiency Ratios
- - - - - - - - - - -
Asset Turnover
0.00 0.78 0.73 0.65 0.00 0.56 0.65 0.73 0.75 0.73 0.69
Accounts Receivable Turnover
0.00 6.23 6.09 6.08 0.00 6.23 6.75 7.38 7.94 7.63 7.49
Inventory Turnover
0.00 5.64 5.40 5.44 0.00 5.59 5.76 5.61 5.42 5.06 4.78
Fixed Asset Turnover
0.00 1.95 1.79 1.62 0.00 1.33 1.50 1.76 1.96 1.81 1.61
Accounts Payable Turnover
0.00 3.14 3.04 3.19 0.00 3.16 3.25 4.69 7.56 7.20 7.39
Days Sales Outstanding (DSO)
0.00 58.59 59.97 60.06 0.00 58.63 54.08 49.46 45.99 47.85 48.73
Days Inventory Outstanding (DIO)
0.00 64.76 67.62 67.15 0.00 65.29 63.36 65.02 67.37 72.18 76.35
Days Payable Outstanding (DPO)
0.00 116.25 119.93 114.46 0.00 115.51 112.18 77.80 48.26 50.72 49.37
Cash Conversion Cycle (CCC)
0.00 7.10 7.66 12.74 0.00 8.41 5.26 36.68 65.09 69.32 75.71
Capital & Investment Metrics
- - - - - - - - - - -
Invested Capital
0.00 19,422 22,156 25,584 26,155 25,538 26,300 26,091 25,409 32,322 38,482
Invested Capital Turnover
0.00 2.69 1.25 1.15 0.00 1.00 1.13 1.25 1.36 1.23 1.06
Increase / (Decrease) in Invested Capital
0.00 19,422 2,734 3,428 571 -617 762 -209 -682 6,913 6,160
Enterprise Value (EV)
0.00 0.00 0.00 27,179 38,598 45,909 47,228 32,740 56,643 73,568 98,129
Market Capitalization
0.00 0.00 0.00 19,945 31,471 32,534 41,161 28,805 51,194 62,852 83,650
Book Value per Share
$0.00 $0.00 $20.75 $21.87 $22.56 $15.21 $25.44 $29.22 $27.72 $31.80 $35.81
Tangible Book Value per Share
$0.00 $0.00 $10.42 $10.36 $11.33 $3.49 $13.06 $15.65 $14.16 $13.74 $13.21
Total Capital
0.00 23,388 27,571 36,123 36,854 33,901 32,775 32,676 33,263 36,818 43,131
Total Debt
0.00 8,195 9,581 17,172 17,220 13,554 11,861 9,636 11,642 13,968 17,653
Total Long-Term Debt
0.00 7,906 9,202 9,959 10,604 12,297 11,312 8,145 9,776 10,969 16,478
Net Debt
0.00 4,228 5,501 6,632 6,520 5,190 5,386 3,051 4,681 9,472 13,004
Capital Expenditures (CapEx)
958 897 1,254 1,324 1,374 996 1,167 1,408 1,713 2,306 2,398
Debt-free, Cash-free Net Working Capital (DFCFNWC)
0.00 882 2,019 1,394 538 1,031 1,190 2,347 2,397 3,027 3,528
Debt-free Net Working Capital (DFNWC)
0.00 3,482 4,601 10,602 10,463 8,769 7,012 8,283 8,738 6,786 7,675
Net Working Capital (NWC)
0.00 3,193 4,221 3,389 3,847 7,512 6,463 6,792 6,872 3,787 6,500
Net Nonoperating Expense (NNE)
95 137 -6.88 -1,016 -1,738 241 -56 -919 149 270 471
Net Nonoperating Obligations (NNO)
0.00 4,229 4,166 6,633 6,521 5,191 5,386 3,051 3,788 9,472 13,004
Total Depreciation and Amortization (D&A)
916 1,061 1,208 1,265 1,787 1,624 1,551 1,577 1,633 1,798 2,156
Debt-free, Cash-free Net Working Capital to Revenue
0.00% 3.38% 7.76% 5.08% 0.00% 3.98% 4.07% 7.17% 6.86% 8.51% 9.42%
Debt-free Net Working Capital to Revenue
0.00% 13.35% 17.69% 38.66% 0.00% 33.87% 24.01% 25.31% 25.00% 19.08% 20.50%
Net Working Capital to Revenue
0.00% 12.24% 16.23% 12.36% 0.00% 29.02% 22.13% 20.76% 19.66% 10.65% 17.36%
Earnings Adjustments
- - - - - - - - - - -
Adjusted Basic Earnings per Share
$0.00 $0.00 $2.27 $3.02 $2.41 $142.90 $0.00 $5.07 $4.36 $5.06 $5.54
Adjusted Weighted Average Basic Shares Outstanding
0.00 0.00 838.96M 843.39M 799.64M 795.14M 0.00 752.14M 723.90M 683.30M 673.20M
Adjusted Diluted Earnings per Share
$0.00 $0.00 $2.25 $3.01 $2.39 $141.80 $0.00 $5.03 $4.33 $5.02 $5.51
Adjusted Weighted Average Diluted Shares Outstanding
0.00 0.00 838.96M 843.39M 799.64M 795.14M 0.00 752.14M 729.20M 689.50M 677M
Adjusted Basic & Diluted Earnings per Share
$0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding
0.00 0.00 838.96M 843.39M 799.64M 795.14M 0.00 752.14M 690.36M 676.48M 668.25M
Normalized Net Operating Profit after Tax (NOPAT)
887 1,473 2,298 1,873 0.00 1,406 2,600 2,931 3,445 3,733 4,109
Normalized NOPAT Margin
3.81% 5.65% 8.84% 6.83% 0.00% 5.43% 8.90% 8.96% 9.86% 10.49% 10.97%
Pre Tax Income Margin
4.30% 6.54% 7.78% 7.27% 0.00% 5.62% 10.62% 10.58% 11.49% 13.25% 12.83%
Debt Service Ratios
- - - - - - - - - - -
EBIT to Interest Expense
3.05 4.99 6.38 0.00 0.00 4.28 10.85 10.87 11.13 8.47 6.75
NOPAT to Interest Expense
2.06 3.58 6.36 0.00 0.00 3.21 8.35 8.63 8.57 6.20 5.26
EBIT Less CapEx to Interest Expense
0.83 2.81 2.91 0.00 0.00 2.01 7.14 6.78 6.57 4.70 3.79
NOPAT Less CapEx to Interest Expense
-0.17 1.40 2.89 0.00 0.00 0.94 4.64 4.54 4.01 2.43 2.30
Payout Ratios
- - - - - - - - - - -
Dividend Payout Ratio
52.54% 28.35% 24.86% 21.91% 38.15% 61.97% 35.22% 24.25% 31.74% 49.42% 26.44%
Augmented Payout Ratio
52.54% 28.35% 25.01% 53.79% 93.04% 83.35% 68.58% 54.54% 131.58% 91.51% 57.60%

Quarterly Metrics And Ratios for CRH

This table displays calculated financial ratios and metrics derived from CRH's official financial filings.

Metric Q4 2023 Q1 2024 Q2 2024 Q3 2024 Q4 2024 Q1 2025 Q2 2025 Q3 2025 Q4 2025 Q1 2026 Q2 2026
Period end date 12/31/2023 3/31/2024 6/30/2024 9/30/2024 12/31/2024 3/31/2025 6/30/2025 9/30/2025 12/31/2025 3/31/2026 6/30/2026
DEI Shares Outstanding
- - - - - - - - - 668,250,818.00 668,200,216.00
DEI Adjusted Shares Outstanding
- - - - - - - - - 668,250,818.00 668,200,216.00
DEI Earnings Per Adjusted Shares Outstanding
- - - - - - - - - -0.26 2.22
Growth Metrics
- - - - - - - - - - -
Revenue Growth
0.00% 1.65% -0.57% 3.82% 2.13% 3.41% 5.72% 5.27% 6.16% 9.09% 5.59%
EBITDA Growth
0.00% 51.81% 12.90% 13.78% 32.84% -18.94% 7.82% 8.06% 23.12% 29.89% 18.54%
EBIT Growth
0.00% 9,350.00% 14.67% 13.25% 43.44% -101.06% 4.00% 3.31% 30.11% -2,000.00% 22.59%
NOPAT Growth
0.00% 2,283.84% 12.21% 4.29% 48.98% -62.25% 6.65% 14.41% 20.18% -311.11% -1.57%
Net Income Growth
0.00% 467.74% 8.00% 5.39% 23.73% -185.96% 1.76% 9.36% 46.26% -83.67% 13.44%
EPS Growth
0.00% 420.00% 16.05% 9.44% 5.21% -193.75% 3.19% 12.18% 49.51% -80.00% 13.92%
Operating Cash Flow Growth
0.00% -6.11% -9.12% -8.89% 12.67% 7.44% -7.21% 33.98% 6.78% 6.53% -18.07%
Free Cash Flow Firm Growth
0.00% 0.00% 0.00% 0.00% 0.00% -78.03% -254.12% 8.59% 15.81% 12.96% 39.06%
Invested Capital Growth
0.00% 9.87% 9.40% 19.49% 27.21% 15.83% 19.13% 15.90% 19.06% 11.78% 11.32%
Revenue Q/Q Growth
-14.25% 0.00% 47.77% 8.92% -15.64% -23.83% 51.07% 8.46% -14.93% -21.73% 46.23%
EBITDA Q/Q Growth
-44.14% 0.00% 288.40% 9.53% -34.78% -70.79% 416.63% 9.78% -25.69% -69.18% 371.47%
EBIT Q/Q Growth
-56.51% 0.00% 879.89% 9.40% -44.92% -100.18% 96,400.00% 8.67% -30.63% -102.89% 5,721.43%
NOPAT Q/Q Growth
-53.25% 0.00% 4,020.55% 2.80% -33.22% -98.67% 11,540.29% 10.27% -29.85% -102.34% 5,527.33%
Net Income Q/Q Growth
-56.53% 0.00% 1,048.25% 6.11% -48.96% -113.82% 1,459.18% 14.04% -31.73% -117.36% 939.44%
EPS Q/Q Growth
-46.67% 0.00% 1,075.00% 4.79% -48.73% -114.85% 1,393.33% 13.92% -31.67% -117.88% 918.52%
Operating Cash Flow Q/Q Growth
48.56% 0.00% 308.57% 0.07% 83.71% -124.14% 309.10% 44.48% 46.41% -121.13% 283.28%
Free Cash Flow Firm Q/Q Growth
0.00% 0.00% 53.37% -228.21% -50.07% 22.49% 7.24% 15.28% -38.23% 19.88% 35.05%
Invested Capital Q/Q Growth
-8.12% 0.00% 2.70% 9.80% -2.19% 5.02% 5.63% 6.82% 0.48% -1.40% 5.19%
Profitability Metrics
- - - - - - - - - - -
Gross Margin
33.98% 27.66% 38.07% 38.60% 35.63% 27.19% 39.45% 38.93% 35.64% 27.75% 39.84%
EBITDA Margin
14.09% 8.97% 23.58% 23.71% 18.33% 7.03% 24.04% 24.34% 21.26% 8.37% 26.99%
Operating Margin
9.02% 0.43% 18.95% 18.68% 12.45% 0.27% 18.96% 18.80% 14.93% -0.52% 19.29%
EBIT Margin
8.96% 2.89% 19.18% 19.27% 12.58% -0.03% 18.87% 18.91% 15.42% -0.57% 21.91%
Profit (Net Income) Margin
6.60% 1.75% 13.56% 13.21% 7.99% -1.45% 13.05% 13.72% 11.01% -2.44% 14.02%
Tax Burden Percent
75.89% 115.15% 75.53% 73.30% 71.83% 67.12% 75.85% 79.07% 81.40% 80.36% 69.86%
Interest Burden Percent
97.04% 52.38% 93.57% 93.53% 88.44% 7,300.00% 91.17% 91.78% 87.74% 533.33% 91.61%
Effective Tax Rate
19.07% -19.19% 24.81% 28.02% 14.49% 0.00% 24.20% 22.28% 19.31% 0.00% 30.56%
Return on Invested Capital (ROIC)
10.04% 0.64% 17.31% 15.67% 13.12% 0.21% 15.84% 15.11% 12.74% -0.38% 13.66%
ROIC Less NNEP Spread (ROIC-NNEP)
8.43% 1.87% 16.32% 15.34% 9.57% -0.89% 14.55% 14.28% 11.88% -1.61% 14.17%
Return on Net Nonoperating Assets (RNNOA)
1.48% 0.57% 4.97% 4.99% 2.85% -0.41% 6.74% 7.04% 5.52% -0.86% 7.67%
Return on Equity (ROE)
11.51% 1.21% 22.28% 20.66% 15.97% -0.20% 22.58% 22.15% 18.27% -1.24% 21.33%
Cash Return on Invested Capital (CROIC)
15.36% 0.00% 0.00% 0.00% -10.81% -2.76% -5.76% -3.31% -5.36% 0.54% 0.24%
Operating Return on Assets (OROA)
6.75% 2.22% 14.25% 13.79% 9.13% -0.02% 13.44% 12.72% 10.60% -0.39% 15.04%
Return on Assets (ROA)
4.97% 1.34% 10.07% 9.46% 5.80% -1.06% 9.29% 9.23% 7.57% -1.69% 9.63%
Return on Common Equity (ROCE)
11.09% 1.17% 21.47% 19.68% 15.25% -0.19% 21.57% 20.94% 17.24% -1.17% 20.12%
Return on Equity Simple (ROE_SIMPLE)
0.00% 16.07% 15.99% 15.47% 0.00% 15.67% 0.00% 0.00% 0.00% 0.00% 0.00%
Net Operating Profit after Tax (NOPAT)
634 33 1,375 1,414 944 13 1,467 1,617 1,135 -27 1,444
NOPAT Margin
7.30% 0.51% 14.24% 13.44% 10.64% 0.19% 14.37% 14.61% 12.05% -0.36% 13.40%
Net Nonoperating Expense Percent (NNEP)
1.60% -1.23% 0.98% 0.33% 3.55% 1.10% 1.29% 0.84% 0.87% 1.23% -0.51%
Return On Investment Capital (ROIC_SIMPLE)
1.92% - - - 2.59% 0.03% 3.76% 3.77% 2.66% -0.06% 3.36%
Cost of Revenue to Revenue
66.02% 72.34% 61.93% 61.40% 64.37% 72.81% 60.55% 61.07% 64.36% 72.25% 60.16%
SG&A Expenses to Revenue
21.17% 27.35% 20.18% 20.77% 21.79% 27.13% 20.77% 21.12% 21.16% 27.91% 21.04%
R&D to Revenue
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Operating Expenses to Revenue
24.96% 27.23% 19.12% 19.92% 23.18% 26.92% 20.49% 20.13% 20.71% 28.26% 20.55%
Earnings before Interest and Taxes (EBIT)
778 189 1,852 2,026 1,116 -2.00 1,926 2,093 1,452 -42 2,361
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)
1,224 586 2,276 2,493 1,626 475 2,454 2,694 2,002 617 2,909
Valuation Ratios
- - - - - - - - - - -
Price to Book Value (P/BV)
2.46 2.98 2.48 2.89 2.91 2.82 2.78 3.46 3.49 3.04 2.97
Price to Tangible Book Value (P/TBV)
4.81 6.77 5.48 6.42 6.73 7.06 6.58 9.50 9.45 8.24 8.08
Price to Revenue (P/Rev)
1.46 1.70 1.47 1.79 1.77 1.66 1.71 2.19 2.23 1.85 1.85
Price to Earnings (P/E)
16.11 17.93 15.05 18.14 18.00 18.13 18.78 23.51 22.29 19.14 18.63
Dividend Yield
1.95% 1.95% 2.71% 2.56% 0.00% 0.00% 0.00% 1.21% 0.00% 0.00% 1.41%
Earnings Yield
6.21% 5.58% 6.64% 5.51% 5.56% 5.52% 5.32% 4.25% 4.49% 5.23% 5.37%
Enterprise Value to Invested Capital (EV/IC)
2.23 2.36 2.02 2.25 2.28 2.13 2.11 2.50 2.55 2.28 2.19
Enterprise Value to Revenue (EV/Rev)
1.62 1.97 1.74 2.11 2.07 2.02 2.08 2.59 2.62 2.27 2.26
Enterprise Value to EBITDA (EV/EBITDA)
9.74 11.47 9.70 11.32 10.54 10.53 10.72 13.19 12.87 11.26 10.74
Enterprise Value to EBIT (EV/EBIT)
13.54 15.79 13.22 15.38 14.19 14.49 14.92 18.63 17.94 15.93 14.90
Enterprise Value to NOPAT (EV/NOPAT)
17.58 21.06 17.76 21.35 19.40 19.21 19.59 23.49 23.03 20.62 21.06
Enterprise Value to Operating Cash Flow (EV/OCF)
11.29 13.87 12.62 15.91 14.75 14.35 15.31 17.58 17.45 15.26 16.12
Enterprise Value to Free Cash Flow (EV/FCFF)
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 443.85 962.63
Leverage & Solvency
- - - - - - - - - - -
Debt to Equity
0.54 0.61 0.61 0.60 0.61 0.70 0.67 0.76 0.69 0.76 0.70
Long-Term Debt to Equity
0.45 0.47 0.46 0.46 0.48 0.64 0.62 0.60 0.65 0.65 0.60
Financial Leverage
0.18 0.31 0.30 0.33 0.30 0.47 0.46 0.49 0.47 0.53 0.54
Leverage Ratio
2.08 2.13 2.13 2.16 2.21 2.28 2.26 2.30 2.25 2.35 2.29
Compound Leverage Factor
2.02 1.12 2.00 2.02 1.95 166.42 2.06 2.11 1.98 12.52 2.10
Debt to Total Capital
35.00% 37.92% 37.95% 37.48% 37.94% 41.21% 40.09% 43.16% 40.93% 43.04% 41.25%
Short-Term Debt to Total Capital
5.61% 8.95% 9.31% 8.68% 8.15% 3.83% 2.97% 9.16% 2.72% 5.75% 5.79%
Long-Term Debt to Total Capital
29.39% 28.97% 28.64% 28.80% 29.79% 37.38% 37.12% 34.00% 38.20% 37.29% 35.46%
Preferred Equity to Total Capital
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Noncontrolling Interests to Total Capital
2.31% 2.18% 2.10% 3.48% 3.38% 3.26% 3.26% 3.05% 3.42% 3.42% 3.45%
Common Equity to Total Capital
62.69% 59.90% 59.95% 59.03% 58.68% 55.53% 56.65% 53.79% 55.65% 53.53% 55.30%
Debt to EBITDA
2.00 2.11 2.09 2.11 2.00 2.28 2.24 2.58 2.32 2.41 2.20
Net Debt to EBITDA
0.80 1.46 1.39 1.50 1.36 1.69 1.73 1.89 1.71 1.92 1.77
Long-Term Debt to EBITDA
1.68 1.61 1.58 1.62 1.57 2.07 2.08 2.03 2.16 2.09 1.89
Debt to NOPAT
3.61 3.86 3.82 3.98 3.68 4.16 4.10 4.59 4.14 4.42 4.32
Net Debt to NOPAT
1.45 2.67 2.54 2.83 2.50 3.08 3.17 3.36 3.05 3.52 3.47
Long-Term Debt to NOPAT
3.03 2.95 2.89 3.06 2.89 3.78 3.80 3.62 3.87 3.83 3.71
Altman Z-Score
2.83 2.94 2.80 2.92 2.89 2.66 2.79 2.88 3.00 2.63 2.83
Noncontrolling Interest Sharing Ratio
3.70% 3.77% 3.66% 4.75% 4.52% 4.56% 4.46% 5.47% 5.63% 5.79% 5.67%
Liquidity Ratios
- - - - - - - - - - -
Current Ratio
1.69 1.37 1.43 1.39 1.37 1.63 1.74 1.45 1.74 1.59 1.58
Quick Ratio
1.08 0.81 0.85 0.88 0.83 0.97 1.08 0.96 1.06 0.83 0.98
Cash Flow Metrics
- - - - - - - - - - -
Free Cash Flow to Firm (FCFF)
0.00 -2,599 -1,212 -3,977 -5,969 -4,626 -4,291 -3,636 -5,025 -4,027 -2,615
Operating Cash Flow to CapEx
402.49% 0.00% 556.18% 352.97% 147.49% -108.03% 220.48% 420.04% 423.08% -107.50% 197.72%
Free Cash Flow to Firm to Interest Expense
0.00 -19.54 -7.82 -24.25 -37.31 -25.56 -21.46 -17.40 -22.84 -19.84 -11.89
Operating Cash Flow to Interest Expense
26.63 -5.35 9.58 9.06 17.06 -3.64 6.89 9.53 13.25 -3.03 5.13
Operating Cash Flow Less CapEx to Interest Expense
20.01 -3.60 7.86 6.49 5.49 -7.01 3.77 7.26 10.12 -5.86 2.54
Efficiency Ratios
- - - - - - - - - - -
Asset Turnover
0.75 0.77 0.74 0.72 0.73 0.73 0.71 0.67 0.69 0.69 0.69
Accounts Receivable Turnover
7.94 7.38 5.83 5.71 7.63 7.20 5.87 5.51 7.49 7.35 5.82
Inventory Turnover
5.42 5.05 5.19 5.18 5.06 4.82 4.86 4.88 4.78 4.86 4.85
Fixed Asset Turnover
1.96 1.90 1.87 1.80 1.81 1.74 1.72 1.64 1.61 1.63 1.61
Accounts Payable Turnover
7.56 8.55 6.59 7.74 7.20 8.38 6.98 7.70 7.39 8.50 7.20
Days Sales Outstanding (DSO)
45.99 49.48 62.63 63.92 47.85 50.67 62.18 66.19 48.73 49.65 62.67
Days Inventory Outstanding (DIO)
67.37 72.33 70.35 70.43 72.18 75.80 75.03 74.82 76.35 75.16 75.24
Days Payable Outstanding (DPO)
48.26 42.68 55.35 47.17 50.72 43.58 52.29 47.38 49.37 42.94 50.67
Cash Conversion Cycle (CCC)
65.09 79.12 77.63 87.18 69.32 82.89 84.92 93.63 75.71 81.86 87.25
Capital & Investment Metrics
- - - - - - - - - - -
Invested Capital
25,409 29,305 30,097 33,047 32,322 33,944 35,855 38,300 38,482 37,944 39,914
Invested Capital Turnover
1.38 1.25 1.22 1.17 1.23 1.13 1.10 1.03 1.06 1.06 1.02
Increase / (Decrease) in Invested Capital
0.00 2,632 2,587 5,391 6,913 4,639 5,758 5,253 6,160 4,000 4,059
Enterprise Value (EV)
56,643 69,033 60,912 74,494 73,568 72,336 75,568 95,644 98,129 86,504 87,376
Market Capitalization
51,194 59,550 51,487 63,321 62,852 59,510 62,057 80,652 83,650 70,247 71,497
Book Value per Share
$27.72 $29.10 $30.18 $32.04 $31.80 $31.22 $33.05 $34.65 $35.81 $34.52 $35.97
Tangible Book Value per Share
$14.16 $12.79 $13.67 $14.45 $13.74 $12.47 $13.95 $12.62 $13.21 $12.75 $13.24
Total Capital
33,263 33,414 34,569 37,056 36,818 38,028 39,443 43,331 43,131 43,094 43,461
Total Debt
11,642 12,672 13,118 13,890 13,968 15,671 15,813 18,702 17,653 18,549 17,926
Total Long-Term Debt
9,776 9,680 9,900 10,672 10,969 14,213 14,642 14,734 16,478 16,071 15,410
Net Debt
4,681 8,755 8,699 9,881 9,472 11,587 12,225 13,671 13,004 14,782 14,379
Capital Expenditures (CapEx)
602 -233 267 421 1,851 610 625 474 689 573 571
Debt-free, Cash-free Net Working Capital (DFCFNWC)
2,397 3,396 3,848 4,310 3,027 3,636 4,762 4,936 3,528 5,226 5,208
Debt-free Net Working Capital (DFNWC)
8,738 6,704 7,783 7,390 6,786 6,988 7,638 9,224 7,675 8,506 8,291
Net Working Capital (NWC)
6,872 3,712 4,565 4,172 3,787 5,530 6,467 5,256 6,500 6,028 5,775
Net Nonoperating Expense (NNE)
61 -81 66 25 235 111 135 98 98 153 -67
Net Nonoperating Obligations (NNO)
3,788 8,563 8,646 9,881 9,472 11,587 12,225 13,671 13,004 13,399 14,379
Total Depreciation and Amortization (D&A)
446 397 424 467 510 477 528 601 550 659 548
Debt-free, Cash-free Net Working Capital to Revenue
6.86% 9.69% 10.99% 12.18% 8.51% 10.16% 13.10% 13.38% 9.42% 13.73% 13.48%
Debt-free Net Working Capital to Revenue
25.00% 19.12% 22.24% 20.88% 19.08% 19.52% 21.01% 25.00% 20.50% 22.35% 21.46%
Net Working Capital to Revenue
19.66% 10.59% 13.04% 11.79% 10.65% 15.45% 17.79% 14.24% 17.36% 15.84% 14.95%
Earnings Adjustments
- - - - - - - - - - -
Adjusted Basic Earnings per Share
$0.97 $0.16 $1.89 $1.99 $1.02 ($0.15) $1.95 $2.23 $1.51 ($0.27) $2.22
Adjusted Weighted Average Basic Shares Outstanding
723.90M 687.80M 685.50M 681.60M 683.30M 676.70M 674.80M 672.30M 673.20M 668.50M 667.20M
Adjusted Diluted Earnings per Share
$0.96 $0.16 $1.88 $1.97 $1.01 ($0.15) $1.94 $2.21 $1.51 ($0.27) $2.21
Adjusted Weighted Average Diluted Shares Outstanding
729.20M 693.40M 688.80M 685.50M 689.50M 676.70M 677.70M 675.50M 677M 668.50M 668.80M
Adjusted Basic & Diluted Earnings per Share
$0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding
690.36M 686.68M 682.78M 679.34M 676.48M 676.00M 672.66M 670.27M 668.25M 668.20M 665.28M
Normalized Net Operating Profit after Tax (NOPAT)
611 14 1,298 1,350 912 2.80 1,445 1,532 1,068 -8.40 1,408
Normalized NOPAT Margin
7.04% 0.21% 13.45% 12.84% 10.28% 0.04% 14.16% 13.84% 11.35% -0.11% 13.06%
Pre Tax Income Margin
8.69% 1.52% 17.95% 18.02% 11.13% -2.16% 17.21% 17.35% 13.53% -3.04% 20.07%
Debt Service Ratios
- - - - - - - - - - -
EBIT to Interest Expense
8.55 1.42 11.95 12.35 6.98 -0.01 9.63 10.01 6.60 -0.21 10.73
NOPAT to Interest Expense
6.96 0.25 8.87 8.62 5.90 0.07 7.33 7.74 5.16 -0.13 6.56
EBIT Less CapEx to Interest Expense
1.93 3.17 10.23 9.79 -4.59 -3.38 6.51 7.75 3.47 -3.03 8.14
NOPAT Less CapEx to Interest Expense
0.35 2.00 7.15 6.05 -5.67 -3.30 4.21 5.47 2.03 -2.95 3.97
Payout Ratios
- - - - - - - - - - -
Dividend Payout Ratio
31.74% 53.81% 43.63% 49.72% 49.42% 29.92% 30.22% 29.35% 26.44% 27.62% 27.01%
Augmented Payout Ratio
131.58% 158.87% 134.61% 116.48% 91.51% 67.18% 66.81% 63.66% 57.60% 60.06% 56.44%

Financials Breakdown Chart

Key Financial Trends

CRH’s latest quarter shows a sharp profitability slowdown, but the balance sheet and shareholder returns remain active. In Q1 2026, the company posted a net loss of $180 million on revenue of $7.37 billion, compared with strong profitability in the prior year’s quarters. Cash flow also weakened materially, with operating cash flow turning negative and cash balances declining. At the same time, CRH is still investing in the business, repaying debt, and buying back stock, which suggests management remains confident in the longer-term outlook.

  • Solid balance sheet liquidity: CRH ended Q1 2026 with $3.24 billion in cash and equivalents, plus $40 million in restricted cash.
  • Equity base remains sizable: Total common equity was $23.07 billion, giving the company meaningful financial flexibility.
  • Dividend and buyback activity continue: CRH paid $39 million in dividends and repurchased $332 million of common equity in Q1 2026.
  • Operating margins have been strong in recent prior periods: In Q4 2025, CRH generated $1.41 billion of operating income on $9.42 billion of revenue, showing the business can still produce healthy profitability under better conditions.
  • Debt management is ongoing: The company repaid $207 million of debt in Q1 2026, continuing a pattern of active capital structure management.
  • Revenue remains large but volatile: Q1 2026 revenue of $7.37 billion was below Q4 2025 and several 2025 quarters, indicating some seasonality or demand softness.
  • Working capital remains a major use of cash: Changes in operating assets and liabilities used $1.01 billion in Q1 2026, a key reason operating cash flow was negative.
  • Goodwill and intangibles are significant: CRH reported $12.59 billion of goodwill and $1.96 billion of intangibles, which is common for an acquisitive company but worth monitoring.
  • Q1 2026 was loss-making: Net income came in at negative $180 million, versus $1.04 billion in Q4 2025 and $1.52 billion in Q3 2025.
  • Operating cash flow turned negative: CRH reported negative $616 million in cash from operations in Q1 2026, a major deterioration from the prior quarter’s $2.92 billion.

What changed year over year? Compared with Q1 2025, CRH’s revenue rose from $6.76 billion to $7.37 billion, but the bottom line worsened dramatically from a $98 million loss to a $180 million loss. The bigger issue was margin pressure and unfavorable working capital movement, which pushed operating cash flow deep into negative territory.

Debt and leverage deserve attention. Total debt increased, with $2.48 billion of short-term debt and $16.07 billion of long-term debt at Q1 2026. That said, CRH also generated substantial profit in the recent past and continues to maintain a large cash position, so leverage does not appear immediately alarming, but it should be watched closely if cash generation stays weak.

Bottom line: CRH still looks like a large, financially flexible industrial company with a history of strong earnings and cash generation, but the latest quarter was a clear setback. Investors should watch for a rebound in operating cash flow and a return to profitability before assuming the recent weakness is temporary.

08/03/26 12:00 PM ETAI Generated. May Contain Errors.

CRH Financials - Frequently Asked Questions

According to the most recent income statement we have on file, CRH's financial year ends in December. Their financial year 2025 ended on December 31, 2025.

CRH's net income appears to be on an upward trend, with a most recent value of $3.79 billion in 2025, rising from $792.09 million in 2015. The previous period was $3.52 billion in 2024. See CRH's forecast for analyst expectations on what's next for the company.

CRH's total operating income in 2025 was $5.44 billion, based on the following breakdown:
  • Total Gross Profit: $13.53 billion
  • Total Operating Expenses: $8.09 billion

Over the last 10 years, CRH's total revenue changed from $23.26 billion in 2015 to $37.45 billion in 2025, a change of 61.0%.

CRH's total liabilities were at $32.85 billion at the end of 2025, a 18.3% increase from 2024, and a 82.1% increase since 2016.

In the past 9 years, CRH's cash and equivalents has ranged from $2.54 billion in 2017 to $9.92 billion in 2019, and is currently $4.10 billion as of their latest financial filing in 2025.

Over the last 10 years, CRH's book value per share changed from 0.00 in 2015 to 35.81 in 2025, a change of 3,581.1%.



Financial statements for NYSE:CRH last updated on 7/30/2026 by MarketBeat.com Staff. New filings and market data are monitored continuously.
From Our Partners